Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
An. bras. dermatol ; 91(5,supl.1): 69-71, Sept.-Oct. 2016. graf
Article in English | LILACS | ID: biblio-837954

ABSTRACT

Abstract Leprosy is a chronic infectious disease caused by Mycobacterium leprae. This bacillus has a high predilection for skin and peripheral nerves. The scalp’s anatomical properties do not favor the development of such mycobacterium. We report a case of leprosy with scalp involvement, a rare occurrence in our literature.


Subject(s)
Humans , Male , Adolescent , Scalp Dermatoses/microbiology , Leprosy, Multibacillary/pathology , Scalp/pathology , Scalp Dermatoses/pathology , Biopsy , Alopecia/microbiology , Alopecia/pathology , Leprosy, Multibacillary/complications
2.
An. bras. dermatol ; 91(3): 345-349, tab, graf
Article in English | LILACS | ID: lil-787306

ABSTRACT

Abstract Leprosy is a chronic disease characterized by manifestations in the peripheral nerves and skin. The course of the disease may be interrupted by acute phenomena called reactions. This article reports a peculiar case of type 2 leprosy reaction with Sweet's syndrome-like features as the first clinical manifestation of leprosy, resulting in a delay in the diagnosis due to unusual clinical presentation. The patient had clinical and histopathological features reminiscent of Sweet's syndrome associated with clusters of vacuolated histiocytes containing acid-fast bacilli isolated or forming globi. Herein, it is discussed how to recognize type 2 leprosy reaction with Sweet's syndrome features, the differential diagnosis with type 1 leprosy reaction and the treatment options. When this kind of reaction is the first clinical presentation of leprosy, the correct diagnosis might be not suspected clinically, and established only with histopathologic evaluation.


Subject(s)
Humans , Female , Adult , Sweet Syndrome/diagnosis , Leprosy, Multibacillary/diagnosis , Thalidomide/therapeutic use , Prednisone/therapeutic use , Sweet Syndrome/etiology , Sweet Syndrome/pathology , Sweet Syndrome/drug therapy , Erythema/diagnosis , Leprosy, Multibacillary/complications , Leprosy, Multibacillary/pathology , Leprosy, Multibacillary/drug therapy , Histiocytes/pathology , Leprostatic Agents/therapeutic use , Neutrophils/pathology
3.
Hansen. int ; 39(2): 66-69, 2014. ilus
Article in Portuguese | LILACS, SES-SP | ID: biblio-831070

ABSTRACT

Em 1963, Wade descreveu a hanseníase histoide, que acometia pacientes previamente tratados com dapsona.Caracteriza-se por lesão com aspecto queloideano, na histopatologia vemos histiócitos fusiformes e um grande número de bacilos. Relata-se caso de hanseníase dimorfa virchoviana com padrão de lesão históide, um verdadeiro desafio diagnóstico, a fim de atentar para manifestações atípicas dessa doença e reforçar a importância da confirmação histológica de casos suspeitos de hanseníase históide.


In 1963, Wade described Histoid Leprosy, that affected patients previously treated with dapsone. This type of leprosy is characterized by keloid-like lesions, in which spindle histiocytes and a large number of bacilli can be seen in the histopathology. A case of borderline lepromatous leprosy with histoid pattern is described, a true diagnostic challenge, in order to attempt to atypical manifestations of the disease and reinforce the importance of histological confirmation in suspected cases of histoid leprosy.


Subject(s)
Humans , Male , Aged, 80 and over , Erythema Nodosum/complications , Leprosy, Multibacillary/complications , Leprosy, Multibacillary/diagnosis , Mycobacterium leprae , Elbow
4.
Hansen. int ; 39(2): 70-74, 2014. ilus
Article in Portuguese | LILACS, SES-SP | ID: biblio-831071

ABSTRACT

A reação reversa maculosa consiste no aparecimento abrupto de máculas hipocrômicas, ocorrendo em pacientes hansenianos dimorfos que completaram o tratamento com poliquimioterapia para hanseníase multibacilar. Em geral, surgem entre 6 a 12 meses da alta, com baciloscopia negativa e boa resposta a corticoterapia sistêmica. Ressaltamos a dificuldade em diferenciar recidiva de um episódio reacional, já que não existem critérios clínicos bem estabelecidos que possibilitem este diagnóstico, além de existirem poucos relatos em literatura. Relatamos um caso clínico com diagnóstico de reação reversa macular após período variável de alta do tratamento de hanseniase dimorfa-dimorfa. Foi feita investigação por meio de anamnese rigorosa, exame dermatológico, exame histopatológico da lesão e baciloscopia, excluindo-se os critérios de recidiva, além de analisados dados anteriores do prontuário.O paciente foi submetido a corticoterapia sistêmica,apresentando melhora das lesões. Conclui-seque a reação reversa maculosa deve ser lembrada nos diagnósticos diferenciais com hanseníase recidivada e episódios reacionais clássicos, evitando retratamentos desnecessários.


Macular reversal reaction is the abrupt onset of hypochromic lesions, occurring in borderline leprosy patients who completed treatment with multidrugtherapy for multibacillary leprosy. In general, these reactions appear 6 to 12 months after medical discharge, showing negative skin smear and good response to systemic corticosteroid therapy. We emphasize the difficulty in differentiating relapse cases from leprosy reactions, as there are no well-established clinical criteria that allow this diagnosis, and moreover there are few reports about it in the literature. We report a borderline leprosy case diagnosed with macular reversal reaction after variable period of discharge from treatment. Detailed anamnesis, dermatological and histopathological examination and bacilloscopy, analysis of previous medical records, excluding the relapse criteria, were used for the investigation. The patient was submitted to systemic corticosteroid therapy, with improvement of the lesions. It is concluded that macular reversal reaction should be considered in the differential diagnosis of relapsed leprosy and classic reactional episodes, avoiding unnecessary retreatment.


Subject(s)
Humans , Male , Adult , Leprosy, Multibacillary/complications , Leprosy, Multibacillary/immunology , Immunity, Cellular/immunology , Leprosy, Multibacillary , Remission Induction , Drug Therapy , Drug Therapy, Combination
5.
Mem. Inst. Oswaldo Cruz ; 107(supl.1): 183-189, Dec. 2012. ilus
Article in English | LILACS, SES-SP, HANSEN, HANSENIASE, SESSP-ILSLPROD, SES-SP, SESSP-ILSLACERVO, SES-SP | ID: lil-659757

ABSTRACT

Iron is essential for all organisms and its availability can control the growth of microorganisms; therefore, we examined the role of iron metabolism in multibacillary (MB) leprosy, focusing on the involvement of hepcidin. Erythrograms, iron metabolism parameters, pro-inflammatory cytokines and urinary hepcidin levels were evaluated in patients with MB and matched control subjects. Hepcidin expression in MB lesions was evaluated by quantitative polymerase chain reaction. The expression of ferroportin and hepcidin was evaluated by immunofluorescence in paucibacillary and MB lesions. Analysis of hepcidin protein levels in urine and of hepcidin mRNA and protein levels in leprosy lesions and skin biopsies from healthy control subjects showed elevated hepcidin levels in MB patients. Decreases in haematologic parameters and total iron binding capacity were observed in patients with MB leprosy. Moreover, interleukin-1 beta, ferritin, soluble transferrin receptor and soluble transferrin receptor/log ferritin index values were increased in leprosy patients. Hepcidin was elevated in lepromatous lesions, whereas ferroportin was more abundant in tuberculoid lesions. In addition, hepcidin and ferroportin were not colocalised in the biopsies from leprosy lesions. Anaemia was not commonly observed in patients with MB; however, the observed changes in haematologic parameters indicating altered iron metabolism appeared to result from a mixture of anaemia of inflammation and iron deficiency. Thus, iron sequestration inside host cells might play a role in leprosy by providing an optimal environment for the bacillus.


Subject(s)
Humans , Antimicrobial Cationic Peptides/urine , Cytokines/blood , Iron/metabolism , Leprosy, Multibacillary/blood , Leprosy, Multibacillary/urine , Anemia/microbiology , Case-Control Studies , Disease Progression , Fluorescent Antibody Technique , Homeopathy , Inflammation/microbiology , Leprosy, Multibacillary/complications , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL